Package 70594-023-09

Brand: colistimethate

Generic: colistimethate sodium
NDC Package

Package Facts

Identity

Package NDC 70594-023-09
Digits Only 7059402309
Product NDC 70594-023
Product ID 70594-023_89aaab5f-68ab-4848-b9c6-a4e1051aaf4c
Description

1 VIAL in 1 CARTON (70594-023-09) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2022-02-20
Brand colistimethate
Generic colistimethate sodium
Sample Package No

Linked Drug Pages (1)

Colistimethate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "89aaab5f-68ab-4848-b9c6-a4e1051aaf4c", "openfda": {"unii": ["XW0E5YS77G"], "rxcui": ["1117522"], "spl_set_id": ["13dc3525-1879-4bd8-a922-81bc1397d5af"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (70594-023-09)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL", "package_ndc": "70594-023-09", "marketing_start_date": "20220220"}], "brand_name": "Colistimethate", "product_id": "70594-023_89aaab5f-68ab-4848-b9c6-a4e1051aaf4c", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Polymyxin-class Antibacterial [EPC]", "Polymyxins [CS]"], "product_ndc": "70594-023", "generic_name": "colistimethate sodium", "labeler_name": "Xellia Pharmaceuticals USA LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Colistimethate", "active_ingredients": [{"name": "COLISTIMETHATE SODIUM", "strength": "150 mg/1"}], "application_number": "ANDA205356", "marketing_category": "ANDA", "marketing_start_date": "20220220", "listing_expiration_date": "20261231"}